The Breast
Volume 19, Issue 2 , Pages 133-136 , April 2010

Positive progesterone receptors and cell proliferation index: An independent association with breast cancer in males

  • Antonio Piñero

      Affiliations

    • Department of General Surgery, “Virgen de la Arrixaca” University Hospital, 30120 Murcia, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 968 369677; fax: +34 968 395537.
    • ,
  • Belén Ferri

      Affiliations

    • Department of Pathology, “Virgen de la Arrixaca” University Hospital, Murcia, Spain
    • ,
  • Luis Polo

      Affiliations

    • Department of Pathology, “Virgen de la Arrixaca” University Hospital, Murcia, Spain
    • ,
  • Manuel Canteras

      Affiliations

    • Department of Biostatistics, School of Medicine, Murcia, Spain
    • ,
  • Joaquín Sola

      Affiliations

    • Department of Pathology, “Virgen de la Arrixaca” University Hospital, Murcia, Spain
    • ,
  • Juan Bermejo

      Affiliations

    • Department of Pathology, “Virgen de la Arrixaca” University Hospital, Murcia, Spain

Received 22 April 2009 ,Revised 14 September 2009 ,Accepted 8 January 2010.

References 

  1. National Cancer Institute. Surveillance, epidemiology, and end results (SEER) program. Available from: http://seer.cancer.gov/csr/1975_2004results_merged/sect_04_breast.pdf.
  2. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–57
  3. Basley CS, Wesley MN, Young RC, Lippman E, et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol. 1987;10:55–60
  4. Camila C, Jenny B, Per H, Jonas B. How to treat male breast cancer. Breast. 2007;16(Suppl. 2):S147–S154
  5. Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775–781
  6. Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the Veterans Affairs population: a comparative analysis. Cancer. 2007;109:1471–1477
  7. Tunon de Lara C, Goudy G, McGrogan G, Durand D, Dilhuydy JM, Avril A, et al. Male breast cancer: a review of 52 cases collected at the Institute Bergonie (Boudeaux, France) from 1980 to 2004. Gynecol Obstet Fertil. 2008;36:386–394
  8. Flynn LW, Park J, Patil SM, Cody HS, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008;206:616–621
  9. Goyal A, Horgan K, Kissin M, Yiangou C, Sibbering M, Lansdown M, et al. Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol. 2004;30:480–483
  10. Adami HO, Holmberg L, Malker B, Ries L. Long term survival in 406 males with breast cancer. Br J Cancer. 1985;52:99–103
  11. Mitra D, Manna A, Sikdar SK, Sur PK. A clinicopathological study and its prognostic implication in male breast carcinoma. J Indian Med Assoc. 2007;105:681–683
  12. Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA. Carcinoma of the male breast. Ann Intern Med. 1992;117:771–777
  13. Tarone RE, Chu KC. The greater impact of menopause on ER− and ER+ breast cancer incidence: a posible explanation (United States). Cancer Causes Control. 2002;13:7–14
  14. Giordano SH. A review of the diagnosis and management of male breast cáncer. The Oncologist. 2007;10:471–479
  15. Burga AM, Fadare O, Lininger RA, Tavassoli FA. Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch. 2006;449:507–512
  16. Muir D, Kanthan R, Kanthan SC. Male versus female breast cancer: a population-based comparative immunohistochemicl analysis. Arch Pathol Lab Med. 2003;127:36–41
  17. Piñero A, Polo L, Alonso JL, Salinas J, Canteras M, Sola J, et al. Características inmunohistoquímicas del cáncer de mama:¿hacia una nueva clasificación?. Cir Esp. 2008;84:138–145
  18. Stendahl M, Ryden L, Nordenskjold B, Jönsson PE, Landberg G, Jirström K. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cáncer patients. Clin Cancer Res. 2006;12:4614–4618
  19. Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, et al. Estrogen receptor positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst. 2005;97:1254–1261
  20. Andre S, Pinto AE, Laranjeira C, Quaresma M, Soares J. Male and female breast cancer: differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis. Pathobiology. 2007;74:323–327
  21. Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, Bourke JB, et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res. 1997;17:2335–2338
  22. Heinig J, Jackisch C, Rody A, Koch O, Buechter D, Schneider HP. Clinical management of breast cancer in males: a report of four cases. Eur J Obstet Gynecol Reprod Biol. 2002;102:67–73
  23. Marrelli D, Pinto E, Neri A, Megha T, Gioffre W, Cioppa T, et al. Mib-1 proliferation index is an independent predictor of lymph node metastasis in invasive breast cancer: a prospective study of 675 patients. Oncol Rep. 2006;15:425–429
  24. Orucavic A, Roddy VB, Bloom KJ, Bitterman P, Magi-Galluzzi C, Oleske DM, et al. Predictors of lymph node metastasis in T1 breast carcinoma stratified by patient age. Breast J. 2002;8:349–352
  25. Vincent-Salomon A, Rousseau A, Jouve M, Beuzeboc P, Sigal-Zafrani B, Freneaux P, et al. Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracicline-based preoperative chemotherapy. Eur J Cancer. 2004;40:1502–1508
  26. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JM, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:1947–1955
  27. Rudlowski C, Friedrichs N, Faridi A, Füzesi L, Moll R, Bastert G, et al. Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat. 2004;84:215–223
  28. Dakin Haché K, Gray S, Barnes PJ, Dewar R, Younis T, Rayson D. Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray. Breast Cancer Res Treat. 2007;105:169–175
  29. Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y, et al. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Research. 2009;11:R28
  30. Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 2009;[Epub ahead of print] PMID: 19330525

PII: S0960-9776(10)00003-2

doi: 10.1016/j.breast.2010.01.001

The Breast
Volume 19, Issue 2 , Pages 133-136 , April 2010

Article Tools